Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: October 2023

MissionIRNewsBreaks — Longeveron Inc. (NASDAQ: LGVN; LGVNR) Enters into $4M Registered Direct Offering

Posted on October 12, 2023 by MissionIR

Longeveron (NASDAQ: LGVN), a clinical-stage biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions such as hypoplastic left heart syndrome (“HLHS”), Alzheimer’s disease and Aging-Related Frailty, has entered into a definitive agreement for the issuance and sale shares … Continue reading →

Posted in Small Cap News | Leave a comment

MissionIRNewsBreaks – Canada Nickel Company Inc. (TSX.V: CNC) (OTCQX: CNIKF) Announces Positive BFS for Crawford Project

Posted on October 12, 2023 by MissionIR

Canada Nickel (TSX.V: CNC) (OTCQX: CNIKF) today released results from the bankable feasibility study (“BFS”) for its innovative and wholly owned Crawford Nickel Sulphide Project (“Crawford”). According to the announcement, the results confirm significantly improved economics from its preliminary economic … Continue reading →

Posted in Canada Nickel Company Inc. CNIKF | Leave a comment

MissionIRNewsBreaks – RVL Pharmaceuticals plc (NASDAQ: RVLP) Reaches Agreement Regarding Reorganization of Three US Subsidiaries

Posted on October 12, 2023 by MissionIR

RVL Pharmaceuticals (NASDAQ: RVLP), a specialty pharmaceutical company focused on the commercialization of UPNEEQ(R) (oxymetazoline hydrochloride ophthalmic solution) (“UPNEEQ”), 0.1%, for the treatment of acquired blepharoptosis, or low-lying eyelid, in adults, has announced a prepackaged reorganization of some of its … Continue reading →

Posted in RVL Pharmaceuticals plc. RVLP | Leave a comment

MissionIRNewsBreaks – D-Wave Quantum Inc. (NYSE: QBTS), Satispay Collaboration Results in Quantum-Hybrid App that Optimizes Customer Rewards Initiatives

Posted on October 12, 2023 by MissionIR

D-Wave Quantum (NYSE: QBTS), a leader in quantum computing systems, software and services and the world’s first commercial supplier of quantum computers, is working with Satispay, the leading Italian fintech unicorn revolutionizing mobile payments. The two companies have built a … Continue reading →

Posted in D-Wave Quantum Inc. QBTS | Leave a comment

PaxMedica Inc. (NASDAQ: PXMD) CEO Presents ASD Pipeline and Corporate Presentation at H.C. Wainwright 25th Annual Global Investment Conference

Posted on October 12, 2023 by MissionIR

Howard Weisman, CEO of PaxMedica (NASDAQ: PXMD), a clinical-stage biopharmaceutical company focusing on the development of novel anti-purinergic therapies (“APTs”) for the treatment of Autism Spectrum Disorder (“ASD”) and other serious conditions with intractable neurological symptoms, recently participated in the H.C. … Continue reading →

Posted in PaxMedica Inc. PXMD | Leave a comment

SuperCom Ltd. (NASDAQ: SPCB) to Deploy Its Domestic Violence Monitoring Solution in Finland, Supporting the Country’s Recently Strengthened Law on Restraining Orders

Posted on October 12, 2023 by MissionIR

SuperCom (NASDAQ: SPCB), a leading provider of advanced safety, identification, and security products and solutions to governments as well as public and private organizations globally, recently announced it had secured a new national program to deploy its Domestic Violence Monitoring … Continue reading →

Posted in SuperCom Ltd. SPCB | Leave a comment

MissionIRNewsBreaks — Renovaro BioSciences Inc. (NASDAQ: RENB) Appoints Intel Capital Cofounder to Board

Posted on October 11, 2023 by MissionIR

Renovaro BioSciences (NASDAQ: RENB), a biotechnology corporation focusing on cell, gene and immunotherapy, has announced a new member of its board of directors. Avram Miller, cofounder of Intel Capital, will join the board and will also serve in an advisory role, … Continue reading →

Posted in Renovaro BioSciences Inc. RENB | Leave a comment

MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Reports Rapid Pace of Enrollment in Potentially Pivotal Berubicin Study

Posted on October 11, 2023 by MissionIR

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, is reporting enrollment of 229 participants in its ongoing potentially pivotal study evaluating Berubicin for the … Continue reading →

Posted in CNS Pharmaceuticals Inc. CNSP | Leave a comment

MissionIRNewsBreaks – Canada Nickel Company Inc. (TSX.V: CNC) (OTCQX: CNIKF) to Host Feasibility Study Conference Call and Webcast

Posted on October 11, 2023 by MissionIR

Canada Nickel (TSX.V: CNC) (OTCQX: CNIKF) today announced that it will host a webcast and conference call at 11:00 a.m. Eastern Time on Thursday, Oct. 12, 2023, to discuss the definitive feasibility study for its Crawford Nickel Sulphide Project. Interested … Continue reading →

Posted in Canada Nickel Company Inc. CNIKF | Leave a comment

Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) to Showcase Trademarked REE Separation Process Details in Canadian Autotech Program, U.S. Defense Department Project

Posted on October 11, 2023 by MissionIR

Ucore Rare Metals (TSX.V: UCU) (OTCQX: UURAF), a strategic metals supply chain-focused enterprise, has built a step-by-step series of achievements in its push toward commercializing its trademarked technology for the separation of heavy and light rare earth elements (“REEs”) in … Continue reading →

Posted in Ucore Rare Metals Inc. UURAF | Leave a comment